SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,894,000 | -67.4% | 50,945 | -57.0% | 1.16% | -63.9% |
| Q1 2021 | $8,870,000 | -59.9% | 118,500 | -53.7% | 3.20% | -46.9% |
| Q4 2020 | $22,129,000 | +60.9% | 255,800 | +13.7% | 6.02% | +61.2% |
| Q3 2020 | $13,752,000 | +867.8% | 225,000 | +1025.0% | 3.74% | +1008.3% |
| Q1 2017 | $1,421,000 | +44.4% | 20,000 | +18.5% | 0.34% | -28.5% |
| Q4 2015 | $984,000 | +144.8% | 16,877 | +111.0% | 0.47% | +38.9% |
| Q1 2015 | $402,000 | – | 8,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |